Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation
- PMID: 18090081
- DOI: 10.1097/BRS.0b013e3181573924
Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation
Abstract
Study design: An animal study to achieve posterolateral intertransverse process spine fusion using mesenchymal stem cell (MSC).
Objective: We investigated the effectiveness of graft material for spinal fusion using a rabbit model by examining the MSC with or without osteogenic differentiation.
Summary of background data: Posterolateral spinal fusion is commonly performed. Autogenous bone graft is the gold standard, although various problems are reported. Recently, MSCs from bone marrow have been studied in various fields. Thus, we supposed that MSCs have the ability to spinal fusion.
Methods: Twenty-four mature male Japanese white rabbits (weight, 3.0-4.0 kg) were divided into 4 groups: 1) autologous bone (AG), 2) hydroxyapatite (HA), 3) MSC, and 4) osteogenic MSC (OMSC). Each group underwent fusion of the intertransverse processes. The lumbar spine was harvested en bloc, and the fusion mass was evaluated radiographically, by manual palpation test, and by histologic analysis at 6 weeks after surgery.
Results: Fusion success or failure was assumed based on the results from manual palpation of the harvested spine. Four of 5 rabbits in the OMSC group, 4 of 6 rabbits in the AB group, 2 of 6 rabbits in the MSC group, and none of 6 rabbits in the HA group achieved fusion. In the OMSC group and AG group, new bone formation was observed histologically. In the HA group, fibrous tissue and cartilage were observed and there was no new bone. In the MSC group, less mature bone formation was present in the grafted fragments.
Conclusion: The present study suggested that MSCs that have been cultured with osteogenic differentiation medium may induce the formation of new bone in experimental spinal fusion. Further studies are needed to determine the suitable level of osteogenic differentiate of MSC as well as the most appropriate carrier for MSC.
Similar articles
-
Effects of fibronectin on osteoinductive capability of fresh iliac bone marrow aspirate in posterolateral spinal fusion in rabbits.Spine (Phila Pa 1976). 2008 May 20;33(12):1318-23. doi: 10.1097/BRS.0b013e3181732a5d. Spine (Phila Pa 1976). 2008. PMID: 18496343
-
Use of fluorescence labeled mesenchymal stem cells in pluronic F127 and porous hydroxyapatite as a bone substitute for posterolateral spinal fusion.J Orthop Res. 2009 Dec;27(12):1631-6. doi: 10.1002/jor.20925. J Orthop Res. 2009. PMID: 19489045
-
rhBMP-6 stimulated osteoprogenitor cells enhance posterolateral spinal fusion in the New Zealand white rabbit.Spine J. 2007 May-Jun;7(3):318-25. doi: 10.1016/j.spinee.2006.02.005. Epub 2007 Apr 6. Spine J. 2007. PMID: 17482115
-
Cell technologies for spinal fusion.Spine J. 2005 Nov-Dec;5(6 Suppl):231S-239S. doi: 10.1016/j.spinee.2005.02.008. Spine J. 2005. PMID: 16291118 Review.
-
Mesenchymal stem cell and gene therapies for spinal fusion.Neurosurgery. 2008 Sep;63(3):380-91; discussion 391-2. doi: 10.1227/01.NEU.0000324990.04818.13. Neurosurgery. 2008. PMID: 18812950 Review.
Cited by
-
Differentiation Potential of Human Chorion-Derived Mesenchymal Stem Cells into Motor Neuron-Like Cells in Two- and Three-Dimensional Culture Systems.Mol Neurobiol. 2016 Apr;53(3):1862-1872. doi: 10.1007/s12035-015-9129-y. Epub 2015 Mar 20. Mol Neurobiol. 2016. PMID: 25790953
-
Comparison of Phenotypic Characterization between Differentiated Osteoblasts from Stem Cells and Calvaria Osteoblasts In vitro.Int J Prev Med. 2013 Feb;4(2):180-6. Int J Prev Med. 2013. PMID: 23543256 Free PMC article.
-
The Biological Enhancement of Spinal Fusion for Spinal Degenerative Disease.Int J Mol Sci. 2018 Aug 17;19(8):2430. doi: 10.3390/ijms19082430. Int J Mol Sci. 2018. PMID: 30126106 Free PMC article. Review.
-
Stem Cells in Spinal Fusion.Global Spine J. 2017 Dec;7(8):801-810. doi: 10.1177/2192568217701102. Epub 2017 Sep 1. Global Spine J. 2017. PMID: 29238646 Free PMC article.
-
Preclinical Study of Human Bone Marrow-Derived Mesenchymal Stem Cells Using a 3-Dimensional Manufacturing Setting for Enhancing Spinal Fusion.Stem Cells Transl Med. 2022 Oct 21;11(10):1072-1088. doi: 10.1093/stcltm/szac052. Stem Cells Transl Med. 2022. PMID: 36180050 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials